Courthouse with columns, representing Department of Justice (DOJ) and SEC Enforcement

DOJ Aggressively Pursues Astounding Health Care Fraud in 2019

In the first half of 2019, the United States Department of Justice (“DOJ”) has shown that it intends to aggressively pursue health care providers who engage in fraudulent schemes to enrich themselves at the expense of their patients and American taxpayers. The DOJ has been especially diligent in its investigation and prosecution of health care...

Assortment of pills in news article at Young Law Group website. Also representing REMS

Young Law Group Secures $225M Settlement in INSYS Case

INSYS Agrees to Global Resolution of Claims Arising from Separate DOJ Criminal and Civil Investigations The Department of Justice announced that INSYS Therapeutics, Inc. (“INSYS”) has agreed to pay $225 million to resolve allegations that it paid kickbacks and engaged in other illegal marketing tactics to promote sales of its fentanyl spray, Subsys. According to...

Close up of gavel on desk, representing justice by Young Law Group as well as corporate whistleblowing

Alleged Nationwide Kickback Scheme by Teva Pharmaceuticals Heads to Trial

Young Law Group, Philadelphia, PA. Chief U.S. District Judge Colleen McMahon ruled on February 27th that a False Claims Act suit brought by two former employees of Teva Pharmaceuticals USA, Inc. will proceed to a trial on the merits. In a detailed seventy-page opinion, the Court rejected numerous arguments asserted by Teva Pharmaceuticals USA, Inc....

Spilled Bottle of Yellow Capsule Pills, representing drug Fraud and off-label marketing abuse

Pharmacy Fraud: Consequences of Imprisonment and Fines

Drug Fraud Since 2018 A number of civil settlements and criminal convictions involving pharmacy and drug fraud in 2018 have highlighted a longstanding problem that imperils patient health and burdens American taxpayers with costs measured annually in the millions of dollars. Pharmacy and drug fraud takes many different forms and can involve everyone in the...

Crop doctor with stethoscope in hospital, representing healthcare ads.

Do Drug and Healthcare Ads Push Ethical Boundaries?

In the past four years, pharmaceutical companies have more than doubled their healthcare ad spending, making it the second-fastest growing ad category in the nation. Other healthcare providers, from local hospitals to nationally known cancer treatment centers, are also increasing their advertising. But when do healthcare promotions cross ethical boundaries and the ancient pledge to...

Orange and White Prescription Bottle On Table, suggesting the opioid epidemic

Behind the Opioid Epidemic

Contributing to the Opioid Epidemic The United States Department of Justice and numerous state governments have intervened in numerous qui tam whistleblower suits, including one brought by Philadelphia based law firm Young Law Group against INSYS Therapeutics, Inc. [1]. The suit alleges, among other things, that INSYS engaged in a nationwide illegal scheme to increase...

False Claims Act Lawsuits over REMS Safety Education

REMS Program Results in FCA Lawsuits After a number of whistleblower lawsuits under the False Claims Act, Novo Nordisk will pay approximately $59 million to settle allegations that it minimized the cancer risk of Victoza, a diabetes medication, after the FDA required it to provide safety communications pursuant to a Risk Evaluation and Mitigation Strategies...

Pharma Patients at Risk with New Drugs, Corruption

Two reports on the pharmaceutical industry issued recently put the safety of drugs into question, with one questioning whether new drugs are put on the American market too soon (before all the risks are known) and the other noting the global risks of corruption within the drug industry on public health. Health Risks in New...

Pharma Payments Increase Doctor Brand Prescriptions

For years, many pharmaceutical and medical device companies have paid doctors for speaking engagements as well as offered free meals, gifts and entertainment. A new study by ProPublica analyzing drugmaker spending and Medicare prescription data to conclude that these payments and gifts translate into higher patient prescriptions for brand-name drugs. The analysis concludes that physicians...

Layoffs in Big Pharma: Combatting Pharmaceutical Fraud

Layoffs from Big-Pharma: Do Your Part to Help Fight Pharmaceutical Fraud Unfortunately, many pharmaceutical companies place the pursuit of profits above compliance with the law and the well-being of innocent patients, who place their trust in their products. In order to bolster their bottom line, some Pharma companies engage in fraudulent sales and marketing schemes...

Tag: pharmaceutical fraud